Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases

Cabozantinib yields promising intracranial activity with an acceptable safety profile for patients who developed brain metastases from renal cell carcinoma (RCC), according to study results…

View More Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases